Influence of the kallikrein-kinin system on prostate and breast tumour angiogenesis

Tumor Biology

Volumn 29, Issue 2, 2008, Pages 130-136

  Wright, Jaclyn K ^a   Botha, Julia H ^a   Naidoo, Strinivasen ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Angiogenesis; Breast cancer; Kinin receptors; Prostate cancer; Tissue kallikrein

Indexed keywords

KALLIKREIN;

ANGIOGENESIS; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; KALLIKREIN KININ SYSTEM; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION;

EID: 45549108733     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141918     Document Type: Article

References (23)

1. Bhoola KD, Figueroa CD, Worthy K: Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
2. Leeb-Lundberg LMF, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL: International Union of Pharmacology. XlV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005;57:27-77.
3. Bõrgono CA, Michael IP, Diamandis EP: Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004;2:257-280.
4. Wolf WC, Evans DM, Chao L, Chao J: A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. Am J Pathol 2001;159:1797-1804.
5. Greco S, Elia MG, Muscella A, Romano S, Storelli C, Marsigliante S: Bradykinin stimulates cell proliferation through an extra-cellular-regulated kinase 1 and 2-dependant mechanism in breast cancer cells in primary culture. J Endocrinol 2005;186:291-301.
6. Taub JS, Guo R, Leeb-Lundburg F, Madden JF, Daaka Y: Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res 2003;63:2037-2041.
7. Barki-Harrington L, Bookout AL, Wang G, Lamb ME, Leeb-Lundberg LM, Daaka Y: Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer pc3 cells. Biochem J 2003;371:581-587.
8. Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, Bianchini G, Stillo F, Capogrossi MC, Madeddu P: Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischaemia. Circulation 2001;103:125-132.
9. Emanueli C, Salis MB, Stacca T, Pintus G, Kirchmair R, Isner JM, Pinna A, Gaspa L, Regoli D, Cayla C, Pesquero JB, Bader M, Madeddu P: Targeting kinin B1 receptor for therapeutic neovascularization. Circulation 2002;105:360-366.
10. Ishihara K, Hayashi I, Yamashina S, Majima M: A potential role of bradykinin in angiogenesis and growth of s-180 mouse tumours. Jpn J Pharmacol 2001;87:318-326.
11. Naidoo S, Raidoo D, Mahabeer R, Mclean M: Tumour metabolites regulate tissue kallikrein in human umbilical vein endothelial cells. Biochim Biophys Acta 2004;1691:117-127.
12. Naidoo S, Raidoo DM: Tissue kallikrein and kinin receptor expression in an angiogenic co-culture neuroblastoma model. Metab Brain Dis 2006;21:253-265.
13. Naidoo S: The role of the kallikrein-kinin cascade and metabolites in angiogenesis and tumourigenesis;thesis, University of Kwa-Zulu-Natal, Durban, 2005.
14. Fulga TA, Rørth P: Invasive cell migration is initiated by guided growth of long cellular extensions. Nat Cell Biol 2002;4:715-719.
15. Foda HD, Zucker S: Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today 2001;6:478-482.
16. Keely P, Parise L, Juliano R: Integrins and GTPases in tumour cell growth, motility and invasion. Trends Cell Biol 1998;8:101-106.
17. Folkman J, Haudenschild C: Angiogenesis in vitro. Nature 1980;288:551-556.
18. Stewart JM, Chan DC, Simkeviciene V, Bunn PAJ, Helfrich B, York EJ, Tarasericiene-Stewart L, Bironaite D, Gera L: Bradykinin antagonists as new drugs for prostate cancer. Int Immunopharmacol 2002;2:1781-1786.
19. Zhu B, Block NL, Lokeshwar BL: Interaction between stromal cells and tumour cells induces chemoresistance and matrix metalloproteinase secretion; in Greenwald RA, Zucker S, Golub LM (eds): Inhibition of Matrix Metalloproteinases: Therapeutic applications. New York, New York Academy of Sciences, 1999, pp 642-646.
20. Yayama K, Kunimatsu N, Teranishi Y, Takano M, Okamoto H: Tissue kallikrein is synthesized and secreted by human vascular endothelial cells. Biochim Biophys Acta 2003;1593:231-238.
21. Miura S, Matsuo Y, Saku K: Transactivation of Kdr/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 2003;41:1118-1123.
22. Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F, Ziche M: B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF2 effects. Br J Pharmacol 1998;124:1286-1292.
23. Liekens S, DeClercq E, Neyts J: Angiogenesis: regulators and clinical applications. Biochem Pharmacol 2001;61:253-270.